| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.00092 | 1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.00095 | 1 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.00075 | 1 |